Cargando…

TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells

BACKGROUND: TWIST1 plays a key role in EMT-mediated tumor invasion and metastasis. Since bone metastasis is a hallmark of advanced prostate cancer and is detected in at least 85% of patients who die of this disease, it is of great importance to understand the regulation of the cellular signaling pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eide, Turid, Ramberg, Håkon, Glackin, Carlotta, Tindall, Donald, Taskén, Kristin Austlid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626792/ https://www.ncbi.nlm.nih.gov/pubmed/23368843 http://dx.doi.org/10.1186/1475-2867-13-4

Ejemplares similares

Regulation of PBX3 expression by androgen and Let-7d in prostate cancer
por: Ramberg, Håkon, et al.
Publicado: (2011)

β-Adrenergic Receptor Signaling in Prostate Cancer
por: Braadland, Peder Rustøen, et al.
Publicado: (2015)

Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer
por: Guldvik, Ingrid Jenny, et al.
Publicado: (2022)

Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence
por: Sivanesan, Shivanthe, et al.
Publicado: (2022)

Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target
por: Roberts, Cai M., et al.
Publicado: (2017)

USF2 inhibits C/EBP-mediated transcriptional regulation of the RIIβ subunit of cAMP-dependent protein kinase
por: Dahle, Maria Krudtaa, et al.
Publicado: (2002)

Implication of β2-adrenergic receptor and miR-196a correlation in neurite outgrowth of LNCaP prostate cancer cells
por: Guerriero, Ilaria, et al.
Publicado: (2021)

Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
por: Yang, Qing, et al.
Publicado: (2005)

Modulation of Androgen Receptor by FOXA1 and FOXO1 Factors in Prostate Cancer
por: Zhao, Yu, et al.
Publicado: (2014)

Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling
por: Shaw, Greg, et al.
Publicado: (2008)

LSD1 inhibition attenuates androgen receptor V7 splice variant activation in castration resistant prostate cancer models
por: Regufe da Mota, Sergio, et al.
Publicado: (2018)

Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells
por: Patrikidou, Anna, et al.
Publicado: (2011)

Decreased expression of the Nkx2.8 gene correlates with tumor progression and a poor prognosis in HCC cancer
por: Qu, Lei, et al.
Publicado: (2014)

Harmine inhibits breast cancer cell migration and invasion by inducing the degradation of Twist1
por: Nafie, Ebtesam, et al.
Publicado: (2021)

Androgen receptor signaling in prostate cancer development and progression
por: Lonergan, Peter E, et al.
Publicado: (2011)

INTS6/DICE1 inhibits growth of human androgen-independent prostate cancer cells by altering the cell cycle profile and Wnt signaling
por: Filleur, Stephanie, et al.
Publicado: (2009)

Posttranslational Modification of the Androgen Receptor in Prostate Cancer
por: van der Steen, Travis, et al.
Publicado: (2013)

RNA-Based TWIST1 Inhibition via Dendrimer Complex to Reduce Breast Cancer Cell Metastasis
por: Finlay, James, et al.
Publicado: (2015)

Low β(2)-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism
por: Braadland, Peder Rustøen, et al.
Publicado: (2015)

Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis
por: Vindrieux, David, et al.
Publicado: (2011)

Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells
por: Patrikidou, Anna, et al.
Publicado: (2012)

Statins and adrenal androgen levels in prostate cancer: A new twist
por: Mostaghel, Elahe A
Publicado: (2021)

Nkx3.1 controls the DNA repair response in the mouse prostate
por: Zhang, Hailan, et al.
Publicado: (2015)

Cooperation of loss of NKX3.1 and inflammation in prostate cancer initiation
por: Le Magnen, Clémentine, et al.
Publicado: (2018)

MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells
por: Zhang, Wei, et al.
Publicado: (2015)

miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1
por: Zhang, Dapeng, et al.
Publicado: (2020)

Loss-of-Nkx3.1 Leads to Activation of Discrete Downstream Target Genes during Prostate Tumorigenesis
por: Song, Haengseok, et al.
Publicado: (2009)

Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN
por: Sharma, Pankaj, et al.
Publicado: (2013)

Ebp1 expression in benign and malignant prostate
por: Gannon, Philippe O, et al.
Publicado: (2008)

TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling
por: Roberts, Cai M., et al.
Publicado: (2016)

Androgen up-regulation of Twist1 gene expression is mediated by ETV1
por: Khatiwada, Prabesh, et al.
Publicado: (2020)

TWIST1 promotes invasion through mesenchymal change in human glioblastoma
por: Mikheeva, Svetlana A, et al.
Publicado: (2010)

Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA
por: Kristiansen, Ilka, et al.
Publicado: (2017)

Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research
por: Ramirez-Garrastacho, Manuel, et al.
Publicado: (2021)

Role of IGF-1/IGF-1R in regulation of invasion in DU145 prostate cancer cells
por: Saikali, Zeina, et al.
Publicado: (2008)

Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness
por: Bonfil, R. Daniel, et al.
Publicado: (2021)

The loss of NKX3.1 expression in testicular – and prostate – cancers is not caused by promoter hypermethylation
por: Lind, Guro E, et al.
Publicado: (2005)

Antioxidant Treatment Promotes Prostate Epithelial Proliferation in Nkx3.1 Mutant Mice
por: Martinez, Erin E., et al.
Publicado: (2012)

LIMK2-NKX3.1 Engagement Promotes Castration-Resistant Prostate Cancer
por: Sooreshjani, Moloud A., et al.
Publicado: (2021)

NKX3.1 Expression Contributes to Epithelial–Mesenchymal Transition of Prostate Cancer Cells
por: Saydullaeva, Iroda, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_id3ijav875oqdgemltcj188krh